Abstract
In the absence of core nonhomologous end-joining (NHEJ) factors, antibody gene class switch recombination (CSR) uses an alternative-end joining (A-EJ) pathway to recombine switch (S) region DNA breaks. Previous reports showing decreased S-junction microhomologies in MSH2-deficient mice, and an exonuclease1 (EXO1) role in yeast microhomology mediated end joining suggest that mismatch repair (MMR) proteins might influence A-EJ mediated CSR. We have directly investigated whether MMR proteins collectively or differentially influence the A-EJ mechanism of CSR by analyzing CSR in mice deficient in both XRCC4 and individual MMR proteins. We find CSR is reduced and that Igh locus chromosome breaks are reduced in the MMR/XRCC4 double deficient B cells compared to B cells deficient in XRCC4 alone, suggesting MMR proteins function upstream of double strand break formation to influence CSR efficiency in these cells. Our results show that MLH1, EXO1, and MSH2 are all important for efficient A-EJ mediated CSR, and we propose that MMR proteins convert DNA nicks and point mutations into double strand DNA breaks for both C-NHEJ and A-EJ pathways of CSR. We also find Mlh1-XRCC4- B cells have an increased frequency of direct S-junctions, suggesting that MLH1 proteins may have additional functions that influence A-EJ mediated CSR.
Keywords: B-cells, Antibodies, Knockout Mice, Gene Rearrangement
Introduction
B cells switch from the production of IgM antibodies to other classes of antibodies (IgG, IgE or IgA) by the process of class switch recombination (CSR); CSR alters the antibody effector function without changing the antigen specificity. Antibody effector functions are encoded in the constant gene segments located within the immunoglobulin heavy chain (Igh) locus. To generate different antibody isotypes, DNA breaks are generated in switch (S) regions located upstream of constant gene segments and then joined through long range recombinational events bringing a downstream constant gene segment into close proximity with the antigen specific variable region gene segments (1).
One factor required for the generation of DNA breaks in S regions is activation induced cytidine deaminase (AID) (2). AID deaminates cytidine residues to uracil residues generating U-G nucleotide mispairings in S region sequences (2-7). Current models suggest that AID-induced U-G mispairings are recognized by DNA repair factors such as mismatch repair (MMR) and base excision repair (BER) proteins, which in turn are important for generating double strand DNA (dsDNA) breaks in S regions (8-14).
In the absence of each of the individual MMR proteins, MSH2, MSH6, MLH1, PMS2 or EXO1, CSR is reduced approximately 2-5 fold compared to wild-type (15-19). Previous studies have shown that U-G mispairings are targets of the MMR pathway (20-22), which suggests that MMR proteins recognize AID induced U-G mispairings in S regions and that MMR protein activity at S region U-G mispairings may be similar to the activity of MMR proteins during DNA repair. Evidence suggests that MMR protein activity occurring in S regions increases the frequency of blunt or nearly blunt dsDNA breaks that can be joined by nonhomologous end-joining (NHEJ) factors (11-14).
Factors involved in the NHEJ pathway play a major role in joining S region DNA breaks during the CSR process (1). Characteristic of NHEJ, S junction structures in wild-type mice are direct (defined as no homology present at the junction site) or display short stretches of microhomology (23). An alternative end-joining (A-EJ) pathway can join S region DNA breaks in the absence of the core nonhomologous end-joining factors Ku70, Ku80, XRCC4 or DNA ligase IV, but at a cost of increased Igh associated chromosomal translocations and reduced CSR efficiency (24-29). The more error-prone, and less efficient, alternative end-joining pathway used in the absence of XRCC4 results in S region DNA junctions that exhibit microhomologies mostly ranging in length from 1-7 nucleotides but extending up to 20 nucleotides (24). The pattern of junction structures during A-EJ is different from the pattern observed in wild-type mice; wild-type mice S junctions display an approximate 40% frequency of direct junctions and very few S junctions with greater than 4 nucleotides of microhomology (23).
During CSR, MMR protein activity has been proposed to lead to the generation of blunt or nearly blunt dsDNA breaks for NHEJ (11-14). To investigate if mismatch repair proteins have an effect on A-EJ, we crossed mice deficient in Msh2, Mlh1 or Exo1 with mice that have a conditional deletion of the Xrcc4 gene in mature B cells. We find that MMR proteins are important for CSR in the absence of NHEJ and suggest that MMR protein activity increases the frequency of DNA breaks that can be used for CSR. Our results demonstrate that MMR proteins are important for A-EJ mediated CSR and we propose that MMR proteins function collectively to increase the frequency of DNA substrates for CSR end joining pathways.
Methods and Material
Mouse strains
Exo1+/−, Mlh1+/− and Msh2+/− mice (30-32) were crossed with conditional CD21 cre Xc/− (cXc/−) mice described previously (24) to generate Exo1−/−cXc/−,Mlh1−/−cXc/−, and Msh2−/− cXc/− mice. These mice are referred to as Exo1-XRCC4-, Mlh1-XRCC4- and Msh2-XRCC4- in the text. All animal studies have been reviewed and approved by the Tufts Medical Center Division of Laboratory Animal Medicine.
In-vitro B cell cultures for Flow cytometry
Splenic B cells were purified by negative selection (Easy Sep Mouse B cell Enrichment kit; Stem Cell Technologies) (11). Exo1-XRCC4- and Mlh1-XRCC4- sets of experiments used B cells that were cultured at 0.5×106/mL. Msh2-XRCC4- experiments used B cells that were cultured at 0.7×106/mL. B cell cultures were stimulated to induce IgG3 (20μg/mL LPS), IgG1 (0.5μg/mL αCD40+20ng/mL IL-4), or IgG2a (20μg/mL LPS+100ng/mL IFN-γ) CSR.
Fluorescent in-situ hybridization (FISH)
Metaphases were prepared from B cells stimulated in culture with either LPS (20mg/mL from Sigma) or αCD40 (0.5μg/mL from BD Pharmingen or eBioscience) plus IL-4 (20ng/mL from Peprotech or eBioscience) to induce CSR. Following 4 days of culture, cells were frozen in metaphase by incubating with colcemid (GIBCO), then swollen in 70mM KCl and fixed in 3:1 methanol:acetic acid. Metaphases were then dropped on glass slides to be used for FISH analysis (24). To determine general genomic instability, slides are hybridized with a Cy3-labelled PNA telomeric probe (Cy3-(TTAGGG)3) (Applied Biosystems). For Igh locus instability the 3′ region of the Igh locus is detected using BAC199 and the 5′ region of the Igh locus is detected using BAC207. BAC’s are labeled with either biotin or digoxigenin by nick translation and then hybridized to slides overnight. All three probes used for FISH have been described previously (24). Fifty metaphases are analyzed for each sample. Statistical significance was determined using a Student’s two-tailed t test.
CSR junction amplification and analysis
Splenic B cells were stimulated in vitro as described above. DNA was isolated from 4 day cultures by phenol/chloroform separation and ethanol precipitation. Sμ-Sγ1 junctions were amplified using nested PCR primers, SuO.8 (5′ GATGCTGTCTCTATTCAGTTATAC 3′) and Sγ1O.8 (5′ TTCAGTTAGGACTCCCACAC 3′) for the first round of PCR. The second round of PCR used primer set SuI.8 (5′ GAATCTATTCTGGCTCTTCTTAAGC 3′) and Sγ1I.8 (5′ TTCTGCATTACTCCCAACCTC 3′). Both rounds of Sμ-Sγ1 PCR amplification performed were 35 cycles of 94°C for 30s, 60°C for 30s, 68°C for 4 min. All PCRs were performed using Expand Long Template Taq and Pfu polymerase mix (Roche). PCR products were cloned and sequenced as previously described (11). Sequenced switch junctions were aligned to published sequences MUSIGCD07 and D78344, and analyzed using the EMBOSS program.
Hybridoma Southern Blot analysis
Splenic B cells were cultured for 4 days with 0.5mg/mL αCD40 plus 20ng/mL IL-4 then fused with the myeloma NS-1 cell line and plated at a concentration of 1 cell per well in 96 well plates. IgM+ hybridomas were identified by ELISA. DNA was prepared from individual IgM+ hybridomas and digested overnight with restriction enzymes EcoR1 or EcoR1 plus BamH1. Digested hybridoma DNA was run on a 1% TAE gel then transferred to a nylon membrane (BioRad Zeta Probe) and hybridized with a genomic DNA probe specific to the Cμ region to identify intra-switch region recombinations as described previously (33).
Results
To determine if the MMR proteins MSH2, MLH1 and EXO1 are important for CSR events mediated by the A-EJ pathway, Msh2+/−, Mlh1+/− and Exo1+/− mice were crossed to conditional XRCC4-deficient (CD21 cre Xc/−) mice that have been described previously (24). These crosses generated mice with mature B cells that are deficient in the core NHEJ protein, XRCC4 as well as either MSH2, MLH1 or EXO1. Mature B cells from these mice were used to determine if MMR proteins are important for A-EJ mediated CSR.
To determine if MMR proteins are important for CSR in the absence of XRCC4, B cells from Msh2-XRCC4-, Mlh1-XRCC4- and Exo1-XRCC4- mice were activated in vitro for 4 days to induce CSR to multiple isotypes and then assayed by flow cytometry to determine the percent of cells that class switched. Msh2-XRCC4-, Mlh1-XRCC4- and Exo1-XRCC4-deficient B cells were each analyzed in separate sets of experiments and compared to wild-type or single protein (MSH2, MLH1 or EXO1) deficient B cells from littermate animals. Table I shows the percent of B cells that had undergone CSR during each set of experiments for multiple isotypes and Figure 1 shows representative dot plots depicting the percent of IgG1 positive B cells following 4 days of αCD40 plus IL-4 stimulation. Similar to results previously reported (15, 17-18, 24), EXO1-, MLH1-, MSH2- and XRCC4- deficient B cells have a reduction in CSR compared to wild-type B cells (Figure 1 & Table I). Approximately 50% of wild-type IgG1 CSR occurs in EXO1-deficient B cells, while 20%-40% of wild-type CSR occurs for IgG3 and IgG2a. Similar results were observed for XRCC4-, MSH2- and MLH1-deficient B cells (Table I and Figure 1).
Table I.
Average % cells class switched with standard deviationa
IgG1 | IgG3 | IgG2a | |
---|---|---|---|
WT | 34.7 ± 5.5 | 9.0 ± 1.2 | 26.7 ± 6.9 |
Exo1- | 18.0 ± 7.3 | 1.8 ± 0.5 | 5.8 ± 3.0 |
XRCC4- | 16.3 ± 7.3 | 3.3 ± 0.8 | 6.9 ± 2.1 |
Exo1-XRCC4- | 7.3 ± 3.0bc | 0.9 ± 0.4bc | 1.9 ± 0.5bc |
| |||
WT | 35.0 ± 9.5 | 7.8 ± 1.4 | 22.9 ± 8.6 |
Mlh1- | 16.6 ± 8.2 | 1.5 ± 0.5 | 3.5 ± 1.5 |
XRCC4- | 15.7 ± 5.3 | 2.5 ± 0.8 | 4.0 ± 1.8 |
Mlh1-XRCC4- | 6.7 ± 2.4de | 1.0 ± 0.4de | 1.4 ± 0.4de |
| |||
WT | 39.9 ± 3.1 | 8.7 ± 3.2 | 19.8 ± 5.8 |
Msh2- | 19.0 ± 5.9 | 2.3 ± 0.7 | 5.1 ± 3.0 |
XRCC4- | 11.3 ± 3.0 | 3.6 ± 1.0 | 6.1 ± 1.9 |
Msh2-XRCC4- | 7.2 ± 3.3fg | 1.6 ± 0.5fg | 2.4 ± 1.1fg |
The number of independent experiments performed for each data set equals n. n = 6 for the Exo1 and Mlh1 data sets while were n = 7 for the Msh2 data set.
For the Exo1 data set, 7 Exo1-XRCC4- and 6 WT, Exo1-, and XRCC4- mice were included in these experiments.
P<0.05 when compared to Exo1-,
P<0.05 when compared to XRCC4- as calculated by a 2-tailed t test.
For the Mlh1 data set, 9 Mlh1-XRCC4- mice and 6 WT, Mlh1- and XRCC4- mice were included in these experiments.
P<0.05 when compared to Mlh1-,
P<0.05 when compared to XRCC4- as calculated by a 2-tailed t test.
For the Msh2 data set, analyses of IgG3 and IgG2a included 13 Msh2-XRCC4-, 9 WT, Msh2-, and XRCC4- mice. For IgG1 10 Msh2-XRCC4-, 8 WT and Msh2- and 7 XRCC4- mice were included in these experiments.
P<0.05 when compared to Msh2-,
P<0.05 when compared to Xrcc4- as calculated by a 2-tailed t test.
Figure 1. Reduced IgG1 CSR efficiency in Exo1-XRCC4-, Msh2-XRCC4- and Mlh1-XRCC4- B cells compared to Exo1-, Msh2-, Mlh1- and XRCC4-deficiency alone.
B cells from Exo1-XRCC4-, Msh2-XRCC4- and Mlh1-XRCC4- mice and various control mice were stimulated in vitro for 4 days with αCD40 plus IL4 to induce IgG1 CSR. Following 4 days of culture, B cells were analyzed by flow cytometry to determine percent of B cells that had undergone CSR to IgG1. (A) Representative FACs dot plots of Exo1-XRCC4- and control B cells from one experiment. Gated population represents % of IgG1+ cells. (B) Same as in (A) with Mlh1-XRCC4- B cells. (C) Same as in (A) for Msh2-XRCC4- B cells
In comparison to B cells with single protein deficiencies, we find that B cells deficient in both EXO1 and XRCC4 have a further reduction in CSR. Exo1-XRCC4- double deficient B cells have an approximate two-fold reduction in IgG1 CSR efficiency compared to Exo1- or XRCC4-deficient B cells (Figure 1A). Analyses of Msh2-XRCC4- and Mlh1-XRCC4- double deficient B cells revealed similar results to those observed for Exo1-XRCC4- (Figure 1B-C). All three mouse strains, Exo1-XRCC4-, Msh2-XRCC4- and Mlh1-XRCC4-, have a significant reduction in CSR efficiency to all IgH isotypes analyzed when compared to single protein deficient B cells (Table I). These results demonstrate that EXO1, MLH1 and MSH2 are important for the A-EJ mediated CSR events that occur in XRCC4-deficient B cells. In addition, in the absence of XRCC4, each MMR protein analyzed appears to affect CSR to a similar degree.
Previous studies have shown that in the absence of XRCC4 most CSR junctions display microhomology, and that for some junctions the length of microhomology is longer than what is observed for wild-type (24). Switch junction microhomology lengths are also increased in the absence of MLH1 and EXO1 but decreased in the absence of MSH2 (34, 11). To determine if individual MMR proteins influence switch junction structures during A-EJ we analyzed switch junctions from Exo1-XRCC4-, Mlh1-XRCC4-, Msh2-XRCC4- and compared the joins to those obtained from their XRCC4- littermates. Sμ-Sγ1 switch junctions were cloned and sequenced from B cells activated in vitro from each mouse strain.
Figure 2 shows the frequency of Sμ-Sγ1 switch junction structures that we find in each mouse strain analyzed. All switch junction sequences are listed in Supplemental Figure 1. Similar to previous reports, the XRCC4-deficient B cells contained switch junctions with microhomology or inserts (sequences at the junction that did not align to either Sμ or Sγ1). Analyses of Msh2-XRCC4- and Exo1-XRCC4-deficient B cells revealed a similar pattern of Sμ-Sγ1 switch junction structures as those amplified from their XRCC4- littermates. Exo1-XRCC4- and Msh2-XRCC4-deficient B cells contained both short and long stretches of microhomology as well as inserts at Sμ-Sγ1 junction sites (Figure 2). Thus, the lack of either EXO1 or MSH2 in B cells deficient for XRCC4 does not seem to impact the CSR junction structures.
Figure 2. MLH1-deficiency alters CSR junctions in XRCC4-deficient B cells while Msh2-XRCC4- and Exo1-XRCC4- switch junctions resemble XRCC4-mice.
Sμ-Sγ1 junctions from XRCC4-, Exo1-XRCC4-, Mlh1-XRCC4-, and Msh2-XRCC4- B cells were amplified by PCR and aligned to μ and γ germline sequences. Amount of microhomology at switch junctions was determined by counting the number of uninterrupted shared nucleotide (nt) identity with Sμ and Sγ sequences at the junction. Cultures from 3 Exo1-XRCC4-, 3 Msh2-XRCC4-, and 2 Mlh1-XRCC4- mice were used to generate the Sμ-Sγ1 junctions. The slight difference in the percent of junctions with ≥5nts of microhomology observed for Msh2-XRCC4- and other XRCC4-deficient strains is not statistically different.
Similar to Sμ-Sγ1 junctions from Exo1-XRCC4- and Msh2-XRCC4-deficient B cells, Sμ-Sγ1 junctions from Mlh1-XRCC4-deficient B cells display both short and long stretches of microhomology as well as inserts (Figure 2). However, unlike Exo1-XRCC4- and Msh2-XRCC4-deficient B cells, there is substantial increase in the level of direct join switch junctions that do not contain microhomology in Mlh1-XRCC4 deficient B cells compared to XRCC4-deficient B cells alone. (Figure 2). This result suggests that the absence of the MLH1 protein alters the pattern of switch junction structures that occur during CSR in XRCC4-deficient B cells. We propose that this altered switch junction pattern may result from a change in the types of DNA ends available for CSR in the absence of MLH1 (see Discussion).
In the absence of XRCC4, in vitro CSR induction results in the presence of Igh locus DNA breaks that are not repaired (24). We therefore investigated if MMR protein deficiency affects the frequency of Igh locus chromosomal breaks that occur in the absence of XRCC4. To determine the frequency of Igh locus chromosomal breaks, we performed fluorescent in-situ hybridization (FISH) assays using B cells that were fixed in metaphase following four days of in vitro culture with αCD40 plus IL-4. The DNA breaks are detected as chromosomal aberrations visualized by FISH using probes specific for the 3′ and 5′ regions of the Igh locus (Figure 3A-C).
Figure 3. Igh locus chromosome aberrations are decreased in Exo1-XRCC4-, Msh2-XRCC4- and Mlh1-XRCC4- double deficient B cells compared to XRCC4-deficient B cells.
(A) Metaphases were prepared from B cells cultured with αCD40 plus IL4 for four days. Metaphases were hybridized with fluorescently labeled BAC199 and BAC207 which are specific for regions 3′ and 5′of the Igh locus. Picture shows chromosomes from an individual metaphase with an intact Igh locus (normal). (B) As in (A) where pictures show chromosomes from individual metaphases with an Igh locus associated break. (C) As in (A) where pictures show chromosomes from individual metaphases with Igh locus associated translocations. Cartoons depicting the status of each Igh locus shown in the metaphase pictures are displayed below the pictures. Pictures of Igh locus breaks and translocations are from the XRCC4-deficient strains analyzed. (D) Bar graphs represent percent of metaphases with Igh locus specific chromosomal aberrations from Exo1-XRCC4- and littermate controls. Total number of metaphases analyzed are in parentheses below each bar graph. 7 Exo1-XRCC4- mice, 6 WT, 6 XRCC4-, and 3 Exo1-mice were used. (E) As in (D), results are from 5 Mlh1-XRCC4 mice, 4 XRCC4-, 4 Mlh1- and 3 WT. (F) As in (D), results are from 9 Msh2-XRCC4- mice, 5 XRCC4-, 5 WT, and 4 Msh2- mice. Statistical significance was determined using a two-tailed T test. (G) Bar graphs represent the percent of DNA breaks observed that were chromosomal (unshaded) versus chromatid (black shaded) breaks. (H) Bar graphs represent the percent of abnormal chromosomes that had free (unshaded) versus translocated (black shaded) DNA ends.
FISH analysis was used to investigate if the decreased CSR in double deficient B cells is the result of an increase in switch region DNA breaks that either cannot be joined or are joined aberrantly in a chromosome translocation event. We first determined the frequency of Igh locus breaks detectable by FISH in the context of MMR protein deficiency alone. Wild-type B cells were included in each experiment as a control. Similar to previously published results, B cells from wild-type mice had few detectable Igh locus chromosome aberrations (Figure 3D-F). Furthermore, Igh locus breaks were not detected at levels above wild-type in EXO1-, MLH1- and MSH2-deficient B cells (Figure 3B).
We next performed the same FISH assay using B cells from Exo1-XRCC4-, Mlh1-XRCC4- and Msh2-XRCC4- as well as wild-type and XRCC4- littermate controls. Figure 3 displays the percent of cells with chromosomal aberrations as well as the types of aberrations observed for the various mouse strains. Wild-type B cells had few detectable Igh locus chromosome aberrations (1.4%), while aberrations were present in approximately 15% of XRCC4-deficient B cells. We find that B cells from each of the Exo1-XRCC4-, Mlh1-XRCC4- and Msh2-XRCC4- double deficient strains have a lower frequency of Igh locus chromosomal aberrations than B cells deficient in XRCC4 alone. Exo1-XRCC4-, Mlh1-XRCC4- and Msh2-XRCC4- mouse strains have 40%-50% fewer B cells with Igh locus chromosomal aberrations following 4 days of in vitro αCD40 plus IL-4 stimulation compared to XRCC4-deficiency alone (Figure 3D-F and Supplemental Tables 1-3). In addition, no difference in cell survival during CSR activation was observed between XRCC4-deficient B cells compared to double deficient B cells demonstrating the reduction in IgH breaks in these cells is not due to an increase in the death of cells that contain breaks (Supplemental Figure 2). These results suggest MMR protein activity may be involved in the generation of dsDNA breaks that persist in the absence of XRCC4. MMR protein activity may lead to the generation of dsDNA breaks that can be used for CSR by converting widely-spaced DNA nicks into double strand DNA breaks (11-14). Therefore the reduced CSR efficiency of MMR/XRCC4 double deficient B cells compared to XRCC4 deficiency alone may be due to a decrease in the overall number of switch region DNA breaks/substrates that can be used for CSR during MMR protein deficiency.
While MMR protein deficiency decreased the frequency of Igh locus chromosome aberrations, the types of aberrations observed were similar to XRCC4-deficiency alone. A majority of the chromosomal aberrations found in XRCC4-deficient B cells are chromosome breaks characterized by a loss of the 5′ signal (BAC207) on both sister chromatids, indicative of breaks that occur during the G1 phase of the cell cycle when CSR is ongoing (35, 12). Similar to XRCC4-deficient B cells, we find that the Igh locus chromosome aberrations observed in Exo1-XRCC4-, Mlh1-XRCC4- and Msh2-XRCC4- deficient B cells are mainly chromosome breaks. For all mouse strains analyzed very few chromatid breaks characterized by a loss of the 5′ signal on one sister chromatid were observed (Figure 3G and Supplemental Tables 1-3).
In XRCC4-deficient B cells, on average 16% of the Igh locus aberrations are translocations (# of translocations / # of aberrations) (24 and Supplemental Tables 1-3). The proportion of the total aberrations that are characterized as chromosome translocations is approximately 15% for both Mlh1-XRCC4- and Msh2-XRCC4-deficient B cells, similar to the proportion observed for XRCC4-deficient B cells (Fig. 3H and Supplemental Tables 2-3). Chromosome translocations account for less than 5% of the Igh locus aberrations in Exo1-XRCC4-deficient B cells (Fig. 3H and Supplemental Table 1), an approximate 67% reduction compared to XRCC4-deficiency alone. The decrease in translocations in Exo1-XRCC4-deficient B cells compared to XRCC4-deficient B cells could suggest a possible role for EXO1 in the error prone pathway of A-EJ that is responsible for the translocations.
To determine if the reduction in chromosome aberrations in the absence of MMR is an Igh specific effect or an overall general effect we performed a second FISH assay using a telomere specific probe (Figure 4A). This assay allowed us to determine genome-wide instability by identifying chromosome aberrations positioned on any of the 40 mouse chromosomes. First, genome-wide genomic instability was determined during MMR protein deficiency alone. Using a telomere specific probe in FISH analyses, we find that following IgG1 CSR induction, MSH2-, MLH1- and EXO1-deficient B cells display a slightly higher level of genome-wide chromosome aberrations than wild-type B cells (Figure 4 and Supplemental Table 4). Approximately 8%-10% of MMR deficient B cells contained chromosome aberrations, most of which were characterized as chromosome breaks (Figure 4 and Supplemental Table 4). A slight increase in genome-wide genomic instability was also observed following 4 days of LPS activation (Supplemental Table 5). This result suggests that MMR proteins are important for repair of some genome-wide damage that occurs following in vitro CSR induction.
Figure 4. General genomic instability is unchanged in Exo1-XRCC4-, Msh2-XRCC4- and Mlh1-XRCC4- double deficient mice compared to XRCC4-deficient mice.
(A) Metaphases were prepared from B cells cultured with αCD40 plus IL4 for four days. Metaphases were hybridized with a fluorescently labeled telomere specific probe. Pictures show chromosomes from individual metaphases that are normal or contain DNA breaks or translocations. Cartoons depicting the status of the chromosomes shown in the metaphase pictures are displayed below the pictures. (B) Bar graphs represent percent of metaphases with chromosomal aberrations from 3 Exo1, 4 Mlh1-, 4 Msh2-, or 9 WT control mice. (C) As in (B), results are from 5 Exo1-XRCC4-, 3 WT and 4 XRCC4- mice. (D) As in (B), results are from 7 Mlh1-XRCC4 mice, 4 XRCC4- and 3 WT. (E) As in (B), results are from 9 Msh2-XRCC4- mice, 5 XRCC4- and 4 WT mice. Statistical significance was determined using a two-tailed T test.
We next assayed Exo1-XRCC4-, Mlh1-XRCC4- and Msh2-XRCC4-deficient B cells for genome-wide chromosome aberrations using the telomere specific probe. For comparison, wild-type and XRCC4-deficient B cells were included in each experiment. The frequencies of genome-wide chromosomal aberrations observed for each mouse analyzed are shown in Figure 4 and Supplemental Tables 6-8. As previously reported, chromosomal aberrations are observed at a high frequency in XRCC4-deficient B cells following CSR induction. We also find high frequencies of chromosomal aberrations in Exo1-XRCC4-, Mlh1-XRCC4- and Msh2-XRCC4-deficient B cells following CSR induction. We find that the frequency of genome-wide chromosome aberrations in Exo1- XRCC4-, Mlh1-XRCC4-, and Msh2-XRCC4- mouse strains is similar to the frequency in XRCC4- alone (Fig. 4). A slight reduction in the percent of cells with genome-wide chromosome aberrations is observed, but the reduction is equivalent to the reduction in the percent of cells with Igh locus chromosome aberrations, suggesting that most of the decrease found using the telomere specific probe is due to the decrease in the Igh locus. Therefore, MMR deficiency does not appear to result in a decreased frequency of chromosome aberrations outside the Igh locus. These results may suggest the MMR protein affect on chromosome aberrations is an Igh locus specific affect.
CSR efficiency in Exo1-XRCC4-, Mlh1-XRCC4-, and Msh2-XRCC4-deficient B cells is decreased compared to XRCC4-deficient B cells; however, the decrease in CSR does not lead to increased Igh locus breaks or translocations. This suggests either fewer switch region DNA breaks occur, or that the DNA breaks are repaired by another mechanism. One such mechanism possible is intra-switch region recombination, where CSR induced DNA breaks within the same switch region are joined to one another (36-37). The frequency of intra-switch region recombination events can be determined using genomic DNA from IgM+ B cell hybridomas generated following in vitro activation of CSR. Sμ internal recombination can be detected by southern blot as a change in the size of a restriction enzyme digest fragment detected with a Cμ probe (Figure 5).
Figure 5. Sμ Intra switch region recombination occur at similar levels in MMR-deficient B cells compared to WT.
B cells from WT, Msh2-, Mlh1- and Exo1- mice were isolated and stimulated in vitro for 4 days with αCD40 plus IL4 to induce CSR. Following 4 days of culture, B cells were fused to the NS1 myeloma cell line to generate hybridomas. IgM+ hybridomas were assayed by southern blot for internal Sμ recombination. Representative southern blots hybridized with a Cμ probe to detect ISR. Δ symbol signifies hybridomas with ISR. 4 WT, 3 Mlh1−/−, 3 Exo1−/−, and 2 Msh2−/− mice were used for this analysis.
To investigate if EXO1-, MLH1- or MSH2-deficiency leads to an increased frequency of intra-switch region recombination events, we performed Southern blot analysis using a Cμ probe on IgM+ hybridomas generated from Exo1-, Mlh1-, Msh2-, as well as wild-type B cells activated in vitro for 4 days with αCD40 plus IL-4. For wild-type controls we find 27% of IgM+ hybridomas have undergone an Sμ internal recombination event (Figure 5 and Supplemental Table 9), similar to previously published wild-type results (26). We find MSH2-deficient IgM+ hybridomas have a similar frequency of Sμ intra-switch region recombination events as wild-type (Figure 5 and Supplemental Table 9). Approximately 45% of IgM+ B cell hybridomas deficient in MLH1 or EXO1 have Sμ internal recombinations. EXO1- and MLH1-deficiencies result in a slightly higher, but non-statistically significant increase in intra-switch region recombination events compared to wild-type. Because intra-switch region recombination events are not increased, and no detectable increase in chromosome breaks are observed by FISH in MMR-deficient B cells, these results suggest that the defect in CSR of MMR-deficient B cells could be due to a decrease in the overall number of switch region double strand DNA breaks.
Discussion
During antibody class switch recombination, switch region DNA breaks can be joined by NHEJ factors. In the absence of classical-NHEJ, an A-EJ pathway is used to join switch region DNA breaks during CSR. Previous studies investigating CSR during MMR protein deficiency showed that MMR proteins are critical for CSR in the absence of the switch μ tandem repeat region, and that they are important for generating a high frequency of blunt dsDNA breaks in switch regions, suggesting that MMR proteins are important for NHEJ mediated CSR (11-13). We have crossed mice deficient in the individual MMR proteins, MSH2, MLH1 and EXO1 with mice that have a conditional deletion of XRCC4 in mature B cells to investigate if MMR proteins have additional individual or collective roles in other end joining pathways of CSR. In our studies we have determined that MSH2, MLH1 and EXO1 each influence CSR events that occur in the absence of the core NHEJ factor XRCC4. We find that Msh2-XRCC4-, Mlh1-XRCC4- and Exo1-XRCC4-deficient B cells have further reductions in CSR when compared to the corresponding single protein deficient B cells. These findings demonstrate that MSH2, MLH1 and EXO1 each influence the efficiency of A-EJ mediated CSR and show that the MMR proteins are important for CSR events mediated by A-EJ.
In the absence of the core NHEJ factors Ku70, XRCC4 or DNA ligase IV, B cells that are activated to undergo CSR contain Igh locus associated chromosome breaks and translocations (24, 26). The presence of these Igh associated chromosome breaks and translocations suggest that the A-EJ pathway, operating in the absence of NHEJ, is (1) more error prone than NHEJ and (2) not capable of repairing all of the switch region DNA breaks that are generated in response to CSR induction. The inability to join some switch region DNA breaks in the absence of NHEJ factors results in a significant decreased CSR efficiency.
The reduced CSR efficiency that we observe in MMR/XRCC4 double deficient B cells (compared to XRCC4-deficient B cells) could result from a further decrease in the fraction of IgH breaks that are able to be joined during CSR. However, we also find that B cells deficient in both MMR and XRCC4 exhibit fewer unrepaired CSR induced Igh locus chromosome breaks when compared to XRCC4-deficient B cells. This finding indicates that the decreased CSR in MMR/XRCC4-deficient B cells is not caused by an increased fraction of unrepairable Igh locus DNA breaks. Instead, our observations suggest that, when both MMR and XRCC4 proteins are absent, less AID-induced DNA damage is converted into Igh locus double strand DNA breaks that can be used by end joining factors for CSR. Therefore, we conclude that the major role of MMR proteins during CSR is to convert AID-induced DNA damage into suitable broken DNA substrates for both C-NHEJ and A-EJ pathways. This conclusion is in accordance with previous studies showing that MMR proteins are important for the generation of S-region dsDNA breaks for CSR in wild-type B cells (12).
During DNA replication, MMR proteins repair base-base mispairings as well as short nucleotide insertions and deletions. DNA repair initiates when MSH2-MSH6 (or MSH2-MSH3) heterodimers recognize DNA damage. Following recognition, MLH1-PMS2 heterodimers and EXO1 are recruited to the sites of DNA damage, resulting in excision of the nucleotide strand that contains the damage. DNA repair is complete once DNA polymerases correctly fill in the gaps left by EXO1 excision (38). Previous reports have proposed a model that describes the activity of MMR proteins during CSR as similar to their activity during DNA repair (11-14).
In our model, MSH2-MSH6 heterodimers recognize U-G mismatches generated by AID in switch region sequences and recruit MLH1-PMS2 and EXO1 to these sites. MLH1-PMS2 and EXO1 then process the DNA surrounding the U-G mismatches, possibly initiating excision at nicks or base excision repair intermediates as previously suggested by Schanz et al. 2009. This activity could convert widely-spaced DNA nicks into double-strand breaks in Igh switch regions that can be used for CSR (11-14). In this model, MMR proteins are critical for optimal CSR efficiency because they generate DNA ends that can be recognized by NHEJ factors during CSR. In a similar manner, CSR efficiency could be reduced in B cells double deficient in MMR and XRCC4 because the collective activity of MMR proteins may also generate DNA ends that can be recognized by A-EJ factors during CSR. Therefore, MMR proteins are critical for efficient CSR mediated by NHEJ and A-EJ because their activity would increase the frequency of DNA ends that can be joined by either of these pathways.
MMR protein activity could generate DNA ends suitable for A-EJ mediated CSR by EXO1 excising DNA past the initial U-G mismatch, leading to DNA ends with short overhangs. Studies investigating EXO1 mediated excision tracts during the MMR repair pathway suggest EXO1 excision likely proceeds slightly past the mismatch before it is inactivated (39). Alternatively, the endonucleolytic activity of the MLH1-PMS2 heterodimer may be important for A-EJ mediated CSR. An endonucleolytic function of the MLH1-PMS2 heterodimer that is dependent on MSH2 mismatch recognition has been identified in human mismatch repair (40). The endonucleolytic activity of MLH1-PMS2 could generate nicks in S region DNA sequences and this activity may lead to increased A-EJ efficiency.
Our results show that Mlh1-XRCC4-deficient B cells have an increase in the frequency of S junctions that are joined without microhomology compared to XRCC4-deficiency alone. No increase in direct S junctions is observed in Msh2-XRCC4- or Exo1-XRCC4-B cells, suggesting MLH1 may have an additional function independent of other MMR proteins during CSR. A function for Mlh1 independent of other MMR proteins was also previously suggested when switch junctions from Msh2-Mlh1- double deficient B cells were found to more closely resemble Mlh1- single deficient B cell junctions than Msh2-deficient B cell junctions (41).
During CSR, the A-EJ pathway almost exclusively uses microhomology to join S region DNA breaks in the absence of XRCC4 or DNA ligase IV (24-25). These findings suggest the A-EJ pathway of CSR uses microhomology to join S region DNA breaks. However, studies investigating DNA repair in XRCC4- or Ku80-deficient cell lines have demonstrated that while microhomology is used more often, it is not used exclusively for DNA break repair in NHEJ deficient cells (42-44). In addition, approximately 10% of switch junction sequences from Ku70-deficient B cells are joined without the use of microhomology (25). Furthermore, approximately 10-20% of switch junctions from B cells that are deficient in both Ku70 and DNA ligase IV are joined without the use of microhomology (25). Therefore, A-EJ is capable of joining S region DNA breaks without using microhomology, and suggests that S junction structures may depend partially on the DNA ends available for ligation.
An increased frequency of direct S junctions in Mlh1-XRCC4-deficient B cells suggests that the absence of the MLH1 protein alters the structures of S junctions in XRCC4-deficient B cells. One possible explanation for this result is that MLH1 protein presence may influence which DNA ends are available for CSR. One function of MLH1 independent of other MMR proteins is to inhibit recombination between similar but non-identical sequences, particularly when short lengths of homology are present; this role is suggested to possibly prevent recombination events that are damaging to the cell (45). MLH1 may play an active role in inhibiting CSR breaks that lack microhomology (blunt breaks) from being used by the A-EJ pathway.
Based on our results we propose that a major collective function of MSH2, MLH1 and EXO1 is to increase the frequency of substrates for the end joining pathways used for CSR. MMR proteins could recognize U-G mispairings in S region sequences leading to an MMR-like activity that results in an increased number of DNA ends that can be used for CSR. This MMR-like activity may be similar to the activity described previously for MMR proteins during NHEJ mediated CSR (11-12, 14). It is possible that MMR proteins generate DNA nicks in S regions as well as convert widely-spaced DNA nicks into near-blunt DNA ends and DNA ends with short overhangs. This activity would make MMR proteins important for efficient CSR, independent of the dsDNA end-joining repair pathway used.
Supplementary Material
Acknowledgements
We would like to thank Drs. Winfried Edelmann and R.M. Liskay for graciously providing the Exo1 and Mlh1 deficient mice. We would also like to thank Thomas Hickernell for his instruction regarding the FISH experiments and analysis.
Footnotes
This research was supported by the National Institutes of Health grants AI24465 to E.S., AI077595 to F.W.A., and by the Eshe foundation.
References
- 1.Stavnezer J, Guikema JE, Schrader CE. Mechanism and regulation of class switch recombination. Annu Rev Immunol. 2008;26:261–292. doi: 10.1146/annurev.immunol.26.021607.090248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Muramatsu M, Kinoshita K, Fagarasan S, Yamads S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000;102:553–563. doi: 10.1016/s0092-8674(00)00078-7. [DOI] [PubMed] [Google Scholar]
- 3.Chaudhuri J, Tian M, Khuong C, Chua K, Pinaud E, Alt FW. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature. 2003;422:726–730. doi: 10.1038/nature01574. [DOI] [PubMed] [Google Scholar]
- 4.Dickerson SK, Market E, Besmer E, Papavasiliou FN. AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 2003;197:1291–1296. doi: 10.1084/jem.20030481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Petersen-Mahrt SK, Harris RS, Neuberger MS. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature. 2002;418:99–103. doi: 10.1038/nature00862. [DOI] [PubMed] [Google Scholar]
- 6.Pham P, Bransteitter R, Petruska J, Goodman MF. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature. 2003;424:103–107. doi: 10.1038/nature01760. [DOI] [PubMed] [Google Scholar]
- 7.Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2) Cell. 2000;102:565–575. doi: 10.1016/s0092-8674(00)00079-9. [DOI] [PubMed] [Google Scholar]
- 8.Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, Yel L, Forveille M, Kavli B, Krokan HE, Ochs HD, Fischer A, Durandy A. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 2003;4:1023–1028. doi: 10.1038/ni974. [DOI] [PubMed] [Google Scholar]
- 9.Rada C, Williams GT, Nilsen H, Barnes DE, Lindahl T, Neuberger MS. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr Biol. 2002;12:1748–55. doi: 10.1016/s0960-9822(02)01215-0. [DOI] [PubMed] [Google Scholar]
- 10.Rada C, Di Noia JM, Neuberger MS. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol Cell. 2004;16:163–167. doi: 10.1016/j.molcel.2004.10.011. [DOI] [PubMed] [Google Scholar]
- 11.Eccleston J, Schrader CE, Yuan K, Stavnezer J, Selsing E. Class switch recombination efficiency and junction microhomology patterns in Msh2-, Mlh1-, and Exo1-deficient mice depend on the presence of mu switch region tandem repeats. J. Immunol. 2009;183:1222–1228. doi: 10.4049/jimmunol.0900135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Schrader CE, Guikema JE, Linehan EK, Selsing E, Stavnezer J. Activation-induced cytidine deaminase-dependent DNA breaks in class switch recombination occur during G1 phase of the cell cycle and depend upon mismatch repair. J Immunol. 2007;179:6064–6071. doi: 10.4049/jimmunol.179.9.6064. [DOI] [PubMed] [Google Scholar]
- 13.Min IM, Schrader CE, Vardo J, Luby TM, D’Avirro N, Stavnezer J, Selsing E. The Smu tandem repeat region is critical for Ig isotype switching in the absence of Msh2. Immunity. 2003;19:515–524. doi: 10.1016/s1074-7613(03)00262-0. [DOI] [PubMed] [Google Scholar]
- 14.Stavnezer J, Schrader CE. Mismatch repair converts AID-instigated nicks to double-strand breaks for antibody class-switch recombination. Trends Genet. 2006;22:23–28. doi: 10.1016/j.tig.2005.11.002. [DOI] [PubMed] [Google Scholar]
- 15.Bardwell PD, Woo CJ, Wei K, Li Z, Martin A, Sack SZ, Parris T, Edelmann W, Scharff MD. Altered somatic hypermutation and reduced class-switch recombination in exonuclease 1-mutant mice. Nature Immunology. 2004;5:224–229. doi: 10.1038/ni1031. [DOI] [PubMed] [Google Scholar]
- 16.Ehrenstein MR, Rada C, Jones AM, Milstein C, Neuberger MS. Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination. PNAS. 2001;98:14553–14558. doi: 10.1073/pnas.241525998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ehrenstein MR, Neuberger MS. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J. 1999;18:3484–3490. doi: 10.1093/emboj/18.12.3484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Schrader CE, Edelmann W, Kucherlapati R, Stavnezer J. Reduced isotype switching in splenic B cells from mice deficient in mismatch repair enzymes. J. Exp. Med. 1999;190:323–330. doi: 10.1084/jem.190.3.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Martomo SA, Yang WW, Gearhart PJ. A role for Msh6 but not Msh3 in somatic hypermutation and class switch recombination. J. Exp. Med. 2004;200:61–68. doi: 10.1084/jem.20040691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Wang H, Lawrence CW, Li GM, Hays JB. Specific binding of human MSH2.MSH6 mismatch-repair protein heterodimers to DNA incorporating thymine- or uracil-containing UV light photoproducts opposite mismatched bases. J. Biol. Chem. 1999;274:16894–16900. doi: 10.1074/jbc.274.24.16894. [DOI] [PubMed] [Google Scholar]
- 21.Wilson TM, Vaisman A, Martomo SA, Sullivan P, Lan L, Hanaoka F, Yasui A, Woodgate R, Gearhart PJ. Msh2-Msh6 stimulates DNA polymerase eta, suggesting a role for A:T mutations in antibody genes. J Exp Med. 2005;201:637–645. doi: 10.1084/jem.20042066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Schanz S, Castor D, Fischer F, Jiricy J. Interference of mismatch and base excision repair during the processing of adjacent U/G mispairs may play a key role in somatic hypermutation. PNAS. 2009;106:5593–5598. doi: 10.1073/pnas.0901726106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Dunnick W, Hertz GZ, Scappino L, Gritzmacher C. DNA sequences at immunoglobulin switch region sites. Nucleic Acids Res. 1993;21:365–372. doi: 10.1093/nar/21.3.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Yan CT, Boboila C, Souza EK, Franco S, Hickernell TR, Murphy M, Gumaste S, Geyer M, Zarrin AA, Manis JP, Rajewsky K, Alt FW. Igh class switching and translocations use a robust non-classical end-joining pathway. Nature. 2007;449:478–482. doi: 10.1038/nature06020. [DOI] [PubMed] [Google Scholar]
- 25.Boboila C, Yan C, Wesemann DR, Jankovic M, Wang JH, Manis J, Nussenzweig A, Nussenzweig M, Alt FW. Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4. J Exp Med. 2010a;207:417–427. doi: 10.1084/jem.20092449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Boboila C, Jankovic M, Yan CT, Wang JH, Wesemann DR, Zhang T, Fazeli A, Feldman L, Nussenzweig A, Nussenzweig M, Alt FW. Alternative end joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proc Natl Acad Sci U S A. 2010b;107:3034–3039. doi: 10.1073/pnas.0915067107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Pan-Hammarstrom Q, Jones AM, Lahdesmaki A, Zhou W, Gatti RA, Hammarstrom L, Gennery AR, Ehrenstein MR. Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cells. J. Exp. Med. 2005;201:189–194. doi: 10.1084/jem.20040772. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Han L, Yu K. Altered kinetics of nonhomologous end joining and class switch recombination in ligase IV-deficient B cells. J.Exp. Med. 2009;205:2745–2753. doi: 10.1084/jem.20081623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Soulas-Sprauel P, Le Guyader G, Rivera-Munoz P, Abramowski V, Olivier-Martin C, Goujet-Zalc C, Charneau P, de Villartay J. Role for DNA repair factor XRCC4 in immunoglobulin class switch recombination. J. Exp. Med. 2007;204:1717–1727. doi: 10.1084/jem.20070255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Wei K, Clark AB, Wong E, Kane MF, Mazur DJ, Parris T, Kolas NK, Russell R, Hou H, Kneitz B, Yang G, Kunkel TA, Kolodner RD, Cohen PE, Edelmann W. Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility. Genes Dev. 2003;17:603–614. doi: 10.1101/gad.1060603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Baker SM, Plug AW, Prolla TA, Bronner CE, Harris AC, Yao X, Christie DM, Monell C, Arnheim N, Bradley A, Ashley T,R, Liskay M. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet. 1996;13:336–342. doi: 10.1038/ng0796-336. [DOI] [PubMed] [Google Scholar]
- 32.Reitmair AH, Schmits R, Ewel A, Bapat B, Redston M, Mitri A, Waterhouse P, Mittrücker HW, Wakeham A, Liu B. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet. 1995;11:64–70. doi: 10.1038/ng0995-64. [DOI] [PubMed] [Google Scholar]
- 33.Bottaro A, Young F, Chen J, Serwe M, Sablitzky F, Alt FW. Deletion of the Igh intronic enhancer and associated matrix-attachment regions decreases, but does not abolish, class switching at the μ locus. International Immunology. 1998;10:799–806. doi: 10.1093/intimm/10.6.799. [DOI] [PubMed] [Google Scholar]
- 34.Schrader CE, Vardo J, Stavnezer J. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions. J. Exp. Med. 2002;195:367–373. doi: 10.1084/jem.20011877. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Franco S, Gostissa M, Zha S, Lombard DB, Murphy MM, Zarrin AA, Yan C, Tepsuporn S, Morales JC, Adams MM, Lou Z, Bassing CH, Manis JP, Chen J, Carpenter PB, Alt FW. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol Cell. 2006;21:201–214. doi: 10.1016/j.molcel.2006.01.005. [DOI] [PubMed] [Google Scholar]
- 36.Alt FW, Rosenberg N, Casanova RJ, Thomas E, Baltimore D. Immunoglobulin heavy-chain expression and class switching in a murine leukaemia cell line. Nature. 1982;296:325–331. doi: 10.1038/296325a0. [DOI] [PubMed] [Google Scholar]
- 37.Winter E, Kraqinkel U, Radbruch A. Directed Ig class switch recombination in activated murine B cells. EMBO J. 1987;6:1663–1671. doi: 10.1002/j.1460-2075.1987.tb02415.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Kunkel EA, Erie DA. DNA Mismatch Repair. Annu. Rev. Biochem. 2005;74:681–710. doi: 10.1146/annurev.biochem.74.082803.133243. [DOI] [PubMed] [Google Scholar]
- 39.Fang WH, Modrich P. Human strand-specific mismatch repair occurs by a bidirectional mechanism similar to that of the bacterial reaction. J of Biol Chem. 1993;268:11838–11844. [PubMed] [Google Scholar]
- 40.Kadyrov FA, Dzantiev L, Constantin N, Modrich P. Endonucleolytic function of MutLα in human mismatch repair. Cell. 2006;126:297–308. doi: 10.1016/j.cell.2006.05.039. [DOI] [PubMed] [Google Scholar]
- 41.Schrader CE, Vardo J, Stavnezer J. Mlh1 can function in antibody class switch recombination independently of Msh2. J. Exp. Med. 2003;197:1377–83. doi: 10.1084/jem.20022190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Kabotyanski EB, Gomelsky L, Han JO, Stamato TD, Roth DB. Double-strand break repair in Ku86- and XRCC4-deficient cells. Nucleic Acids Res. 1998;26:5333–42. doi: 10.1093/nar/26.23.5333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Guirouilh-Barbat J, Huck P, Bertrand L, Pirzio C, Desmaze L, Sabatier, Lopez BS. Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells. Mol Cell. 2004;14:611–623. doi: 10.1016/j.molcel.2004.05.008. S. [DOI] [PubMed] [Google Scholar]
- 44.Guirouilh-Barbat J, Rass I, Plo P, Bertrand, Lopez BS. Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends. Proc Natl Acad Sci U S A. 2007;104:20902–20907. doi: 10.1073/pnas.0708541104. E. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Siehler SY, Schrauder M, Gerischer U, Cantor S, Marra G, Wiesmuller L. Human MutL-complexes monitor homologous recombination independently of mismatch repair. DNA Repair. 2009;8:242–252. doi: 10.1016/j.dnarep.2008.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.